This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
It’s best to be first, but drugs that are approved later with the same mechanism of action can also create…
Article
10 months ago ●
8 mins read
Context. “Compound 5g” (Incyte) is a selective cyclin-dependent kinase 2 (CDK2) inhibitor. Although CDK2 is a highly pursued cancer drug…
molecule
4 months ago ●
4 mins read
In 2021 the FDA approved four new drugs for various immunological diseases, including a molecular glue, the first drug approved…
Article
10 months ago ●
9 mins read
Context. AZD1656 (AstraZeneca)is an oral glucokinase (GK) activator (GKA) for hyperglycemia in type 2 diabetes mellitus. Despite GK being first…
molecule
4 months ago ●
5 mins read
Drug Hunter’s April 2022 edition of Molecules of the Month features some emerging small molecule clinical candidates as well as…
Article
10 months ago ●
1 min read
Context. JNJ-64264681 (Janssen) is a covalent Bruton’s tyrosine kinase (BTK) inhibitor being developed for hematological malignancies. The first-in-class irreversible BTKi…
molecule
4 months ago ●
4 mins read
Load More
